NPI 1053576504: Open Payments
NPI 1053576504. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$95 in 5 payments from 5 companies in 2025. Trend: 2023 $180 · 2024 $169 · 2025 $95
Food & beverage: $95
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $36 |
| Novo Nordisk Inc | 1 | $16 |
| Boston Scientific Corporation | 1 | $15 |
| Abbott Laboratories | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: Korlym, Wegovy, WaveWriter Alpha Prime 16, FREESTYLE LIBRE 3, VRAYLAR.
